.png){kind=icon}
返回
Exploiting protease activation for therapy
.png){kind=icon}
OA
AI
DOI：10.1016/j.drudis.2022.03.011.png)
.png){kind=icon}
.png){kind=icon}
分享.png){kind=icon}
收藏
摘要
En 中文
Proteases have crucial roles in homeostasis and disease; and protease inhibitors and recombinant proteases in enzyme replacement therapy have become key therapeutic applications of protease biology across several indications. This review briefly summarises therapeutic approaches based on protease activation and focuses on how recent insights into the spatial and temporal control of the proteolytic activation of growth factors and interleukins are leading to unique strategies for the discovery of new medicines. In particular, two emerging areas are covered: the first is based on antibody therapies that target the process of proteolytic activation of the pro-form of proteins rather than their mature form; the second covers a potentially new class of biopharmaceuticals using engineered, proteolytically activable and initially inactive pro-forms of antibodies or effector proteins to increase specificity and improve the therapeutic window.
Keyword:
Protease
Proteolytic activation
Zymogen
Cytokine
Antibody engineering
Therapeutic antibodies
Activatable therapeutics
AI总结
对已上传原文的论文进行重点信息的提取，主要内容包括：简要概述、研究摘要、背景介绍、关键亮点、图文解析、展望与总结。
期刊
IF:
7.5
论文数:
6.4K
被引数:
2.3W
机构
引用论文
Selective Inhibition of Matrix Metalloproteinase-14 Blocks Tumor Growth, Invasion, and Angiogenesis.png)
CANCER RESEARCHOAAI
CANCER RESEARCHIF16.6
OAAI分享收藏The tumor targeting performance of anti-CD166 Probody drug conjugate CX-2009 and its parental derivatives as monitored by 89Zr-immuno-PET in xenograft bearing miceTHERANOSTICSOAAI
THERANOSTICSIF13.3
OAAI分享收藏
查看更多内容